Big pharma sues NHS over medicines price cap British pharmaceutical companies are suing the NHS's drugs watchdog in an effort to prevent drug rationing.
The unprecedented legal action follows a new rule, in place since April, to consider delaying or restricting funding for medicines already judged good value for money by the National Institute for Health and Care Excellence (NICE) if they cost the health service more than £20 million a year.
The Association of the British Pharmaceutical Industry is seeking judicial review of the changes, saying they “contravene the fundamental right to access to cost-effective medicines”. The Daily Telegraph
See also:
The unprecedented legal action follows a new rule, in place since April, to consider delaying or restricting funding for medicines already judged good value for money by the National Institute for Health and Care Excellence (NICE) if they cost the health service more than £20 million a year.
The Association of the British Pharmaceutical Industry is seeking judicial review of the changes, saying they “contravene the fundamental right to access to cost-effective medicines”. The Daily Telegraph
See also:
No comments:
Post a Comment